Featured
The Miracle Molecule: How Next-Generation GLP-1s and AI Are Rewiring Human Longevity in 2026
In a landmark 2026 policy shift, the FDA and CMS have expanded coverage for AI-designed metabolic therapies, moving beyond weight loss to actively pre...
Read Full Story →